Login / Signup

Exometabolomic analysis of susceptible and multi-drug resistant Pseudomonas aeruginosa.

E KoçakŞ NigizE ÖzkanS Erdoğan KablanG HazirolanE NemutluS KırM SağıroğluCeren Ozkul
Published in: Letters in applied microbiology (2022)
Multidrug resistant (MDR) Pseudomonas aeruginosa strains have recently become one of the major public health concerns worldwide leading to difficulties in selecting appropriate antibiotic treatment. Thus, it is important to elucidate the characteristics of MDR isolates. Herein, we aimed to determine the unique exometabolome profile of P. aeruginosa clinical isolates in monocultures that comprise high resistance to multiple antibiotics, and compare the differential metabolite profiles obtained from susceptible isolates by using GC/MS. Our results showed that partial least square-discriminant analysis (PLS-DA) score plot clearly discriminated the MDR and susceptible isolates indicating the altered exometabolite profiles, and highlighted the significantly enriched levels of trehalose and glutamic acid in MDR isolates. Expression of trehalose synthase (treS) was also 1·5-fold higher in MDR isolates, relatively to susceptible isolates. Overall, our study provides insights into the distinct footprints of MDR P. aeruginosa isolates in mono-culture.
Keyphrases
  • multidrug resistant
  • drug resistant
  • acinetobacter baumannii
  • gram negative
  • pseudomonas aeruginosa
  • genetic diversity
  • public health
  • klebsiella pneumoniae
  • poor prognosis
  • replacement therapy